Description

Cimifugin β-D-Glucopyranoside is a bioactive phytochemical compound derived from the roots of *Saposhnikovia divaricata* (Fangfeng). This natural product is valued for its role as a key reference standard and active pharmaceutical ingredient due to its documented anti-inflammatory and immunomodulatory properties. It is primarily utilized by research institutions and manufacturers in the pharmaceutical, nutraceutical, and traditional medicine sectors for quality control, analytical research, and product development.

Application

• Pharmaceutical Reference Standard: Used for the qualitative and quantitative analysis (HPLC, LC-MS) of herbal extracts and finished products containing *Saposhnikovia divaricata*.
• Active Pharmaceutical Ingredient (API) Development: Serves as a critical component in the research and formulation of new therapeutic agents targeting inflammatory pathways.
• Nutraceutical and Dietary Supplement Formulation: Incorporated into high-end supplements for its potential health-benefitting properties.
• Biochemical and Pharmacological Research: Employed in *in vitro* and *in vivo* studies to investigate mechanisms of action, pharmacokinetics, and bioactivity.
• Quality Control in Herbal Medicine: Essential for ensuring the authenticity, potency, and batch-to-batch consistency of raw herbal materials and proprietary blends.
• Cosmeceutical Applications: Explored for use in topical formulations aimed at soothing skin and reducing inflammation due to its natural origin and bioactivity.

Basic Information

Product Name	Cimifugin β-D-Glucopyranoside
CAS No.	80681-45-4
Molecular Formula	C22H28O11
Molecular Weight	468.45 g/mol
Synonyms	4-[(2S,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-methoxy-7-methyl-2H-chromen-2-one; Cimifugin-β-D-glucopyranoside; Cimifugin glucoside; (2'S)-5-Methoxy-7-methyl-2'-oxo-2H,2'H-spiro[chromene-3,1'-cyclopenta[c]furan]-4'-yl β-D-glucopyranoside; Divaricoside
EINECS	Contact for details

Quality Control

Our Cimifugin β-D-Glucopyranoside is produced under strict quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity, identity confirmation by IR and MS, and residual solvent analysis, to ensure it meets the high standards required for research and pharmaceutical applications. A detailed Certificate of Analysis (COA) is provided with every shipment to guarantee traceability, consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at 2-8°C. This product is hygroscopic (moisture-sensitive) and should be handled in a low-humidity environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥98.0%
Loss on Drying	≤2.0%
Residue on Ignition	≤0.1%
Heavy Metals	≤10 ppm
Residual Solvents	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.